Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Provided By GlobeNewswire
Last update: Feb 24, 2025
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 2:30 p.m. EST.
Read more at globenewswire.com
